Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Endocrine Testing Market by Type (Tandem Mass Spectrometry, Immunoassay), By Application (Hospitals, Commercial Laboratories, Ambulatory Care Centres, Other Setting) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Endocrine Testing Market by Type (Tandem Mass Spectrometry, Immunoassay), By Application (Hospitals, Commercial Laboratories, Ambulatory Care Centres, Other Setting) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 296551 4200 Medical Care 377 181 Pages 4.9 (30)
                                          

Industry Growth Insights published a new data on “Endocrine Testing Market”. The research report is titled “Endocrine Testing Market research by Types (Tandem Mass Spectrometry, Immunoassay), By Applications (Hospitals, Commercial Laboratories, Ambulatory Care Centres, Other Setting), By Players/Companies Abbott Laboratories, AdnaGen, Beckman Coulter/Danaher, Biomedical Diagnostics, BioMerieux, Bio-Rad, Dako, DiaSorin, Eiken, Fujirebio, Instrumentation Laboratory, Kyowa Medex, Matritech, Ortho-Clinical Diagnostics, Roche, Siemens, Sysmex, Thermo Fisher, Tosoh, Wako, Wallac/PE”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Endocrine Testing Market Research Report

By Type

Tandem Mass Spectrometry, Immunoassay

By Application

Hospitals, Commercial Laboratories, Ambulatory Care Centres, Other Setting

By Companies

Abbott Laboratories, AdnaGen, Beckman Coulter/Danaher, Biomedical Diagnostics, BioMerieux, Bio-Rad, Dako, DiaSorin, Eiken, Fujirebio, Instrumentation Laboratory, Kyowa Medex, Matritech, Ortho-Clinical Diagnostics, Roche, Siemens, Sysmex, Thermo Fisher, Tosoh, Wako, Wallac/PE

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

181

Number of Tables & Figures

127

Customization Available

Yes, the report can be customized as per your need.


Global Endocrine Testing Industry Outlook


Global Endocrine Testing Market Report Segments:

The global Endocrine Testing market is segmented on the basis of:

Types

Tandem Mass Spectrometry, Immunoassay

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals, Commercial Laboratories, Ambulatory Care Centres, Other Setting

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Abbott Laboratories
  2. AdnaGen
  3. Beckman Coulter/Danaher
  4. Biomedical Diagnostics
  5. BioMerieux
  6. Bio-Rad
  7. Dako
  8. DiaSorin
  9. Eiken
  10. Fujirebio
  11. Instrumentation Laboratory
  12. Kyowa Medex
  13. Matritech
  14. Ortho-Clinical Diagnostics
  15. Roche
  16. Siemens
  17. Sysmex
  18. Thermo Fisher
  19. Tosoh
  20. Wako
  21. Wallac/PE

Global Endocrine Testing Market Overview


Highlights of The Endocrine Testing Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Tandem Mass Spectrometry
    2. Immunoassay
  1. By Application:

    1. Hospitals
    2. Commercial Laboratories
    3. Ambulatory Care Centres
    4. Other Setting
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Endocrine Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Endocrine Testing Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Endocrine testing is a type of medical test that checks the function of the endocrine system. This system includes glands in the body that produce hormones, which control many aspects of our health. Endocrine tests can be used to diagnose problems with the endocrine system, such as diabetes, thyroid disease, and hormonal imbalances.

Some of the major players in the endocrine testing market are Abbott Laboratories, AdnaGen, Beckman Coulter/Danaher, Biomedical Diagnostics, BioMerieux, Bio-Rad, Dako, DiaSorin, Eiken, Fujirebio, Instrumentation Laboratory, Kyowa Medex, Matritech, Ortho-Clinical Diagnostics, Roche, Siemens, Sysmex, Thermo Fisher, Tosoh, Wako, Wallac/PE.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Endocrine Testing Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Endocrine Testing Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Endocrine Testing Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Endocrine Testing Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Endocrine Testing Market Size & Forecast, 2018-2028       4.5.1 Endocrine Testing Market Size and Y-o-Y Growth       4.5.2 Endocrine Testing Market Absolute $ Opportunity

Chapter 5 Global Endocrine Testing Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Endocrine Testing Market Size Forecast by Type
      5.2.1 Tandem Mass Spectrometry
      5.2.2 Immunoassay
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Endocrine Testing Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Endocrine Testing Market Size Forecast by Applications
      6.2.1 Hospitals
      6.2.2 Commercial Laboratories
      6.2.3 Ambulatory Care Centres
      6.2.4 Other Setting
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Endocrine Testing Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Endocrine Testing Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Endocrine Testing Analysis and Forecast
   9.1 Introduction
   9.2 North America Endocrine Testing Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Endocrine Testing Market Size Forecast by Type
      9.6.1 Tandem Mass Spectrometry
      9.6.2 Immunoassay
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Endocrine Testing Market Size Forecast by Applications
      9.10.1 Hospitals
      9.10.2 Commercial Laboratories
      9.10.3 Ambulatory Care Centres
      9.10.4 Other Setting
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Endocrine Testing Analysis and Forecast
   10.1 Introduction
   10.2 Europe Endocrine Testing Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Endocrine Testing Market Size Forecast by Type
      10.6.1 Tandem Mass Spectrometry
      10.6.2 Immunoassay
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Endocrine Testing Market Size Forecast by Applications
      10.10.1 Hospitals
      10.10.2 Commercial Laboratories
      10.10.3 Ambulatory Care Centres
      10.10.4 Other Setting
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Endocrine Testing Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Endocrine Testing Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Endocrine Testing Market Size Forecast by Type
      11.6.1 Tandem Mass Spectrometry
      11.6.2 Immunoassay
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Endocrine Testing Market Size Forecast by Applications
      11.10.1 Hospitals
      11.10.2 Commercial Laboratories
      11.10.3 Ambulatory Care Centres
      11.10.4 Other Setting
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Endocrine Testing Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Endocrine Testing Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Endocrine Testing Market Size Forecast by Type
      12.6.1 Tandem Mass Spectrometry
      12.6.2 Immunoassay
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Endocrine Testing Market Size Forecast by Applications
      12.10.1 Hospitals
      12.10.2 Commercial Laboratories
      12.10.3 Ambulatory Care Centres
      12.10.4 Other Setting
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Endocrine Testing Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Endocrine Testing Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Endocrine Testing Market Size Forecast by Type
      13.6.1 Tandem Mass Spectrometry
      13.6.2 Immunoassay
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Endocrine Testing Market Size Forecast by Applications
      13.10.1 Hospitals
      13.10.2 Commercial Laboratories
      13.10.3 Ambulatory Care Centres
      13.10.4 Other Setting
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Endocrine Testing Market: Competitive Dashboard
   14.2 Global Endocrine Testing Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details â€“ Overview, Financials, Developments, Strategy) 
      14.3.1 Abbott Laboratories
      14.3.2 AdnaGen
      14.3.3 Beckman Coulter/Danaher
      14.3.4 Biomedical Diagnostics
      14.3.5 BioMerieux
      14.3.6 Bio-Rad
      14.3.7 Dako
      14.3.8 DiaSorin
      14.3.9 Eiken
      14.3.10 Fujirebio
      14.3.11 Instrumentation Laboratory
      14.3.12 Kyowa Medex
      14.3.13 Matritech
      14.3.14 Ortho-Clinical Diagnostics
      14.3.15 Roche
      14.3.16 Siemens
      14.3.17 Sysmex
      14.3.18 Thermo Fisher
      14.3.19 Tosoh
      14.3.20 Wako
      14.3.21 Wallac/PE

Our Trusted Clients

Contact Us